Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Triiodothyronine adjunctive therapy in acute schizophrenia
2007-001541-18Phase 2Completed
- Sponsor
- Institute of Psychophysiology and Rehabilitation
- Start
- Mar 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in schizophrenia comparing Risperidone + liothyronine with Risperidone + placebo (2 arms). Primary endpoint: Primary: change in PANSS total score at 6 weeks. Started Mar 2007; status: completed.
02
Drugs
liothyronine
03
Conditions
schizophrenia
Beyond the preview
Go deeper on 2007-001541-18.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2007-001541-18.